The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis.
BACKGROUND
Previous studies have shown inconsistent results on the association between diabetes mellitus (DM) and some clinical outcomes. We conducted a meta-analysis of observational studies to assess effect of DM on clinical outcomes after coronary stenting.


METHODS
We searched for studies without language restriction in PubMed, Embase and Cochrane library prior to 2012. The clinical outcomes including in-stent restenosis (ISR), major adverse cardiac events (MACE), stent thrombosis (ST), target lesion revascularization (TLR) and target vessel revascularization (TVR). Adjusted odds ratio (OR), and the corresponding 95% confidence interval (95% CI) was summarized.


RESULTS
55 studies involving 128,084 total patients (38,416 DM patients and 89,668 controls) were eligible for our analysis. Overall, there were significant associations between DM and ISR (OR = 1.70, 95% CI: 1.53-1.89, I(2) = 0.0%), MACE (OR = 1.54, 95% CI: 1.36-1.73, I(2) = 29.0%), ST (OR = 2.01, 95% CI: 1.36-2.97, I(2) = 47.7%), TLR (OR = 1.46, 95% CI: 1.26-1.68, I(2) = 43.3%) as well as TVR (OR = 1.33, 95% CI: 1.17-1.51, I(2) = 48.3). Subgroup analysis showed that the associations were similar between BMS and DES implantation. Moreover, there was no significant association in the ST subgroup after 1-3 years follow-up.


CONCLUSIONS
Our meta-analysis suggests that after coronary stent implantation, DM is associated with ISR, MACE, ST, TLR and TVR. DM appears to be a vital risk factor of these clinical outcomes.
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
Shan-Yu
SY
Qin
You
Y
Zhou
Hai-Xing
HX
Jiang
Bang-Li
BL
Hu
Lin
L
Tao
Min-zhi
MZ
Xie
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D016001:Confidence Intervals; D003920:Diabetes Mellitus / Q000503:physiopathology*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D006801:Humans; D012307:Risk Factors